By Kelly Knaub ( September 8, 2016, 9:16 PM EDT) -- The Federal Circuit on Thursday affirmed a lower court's ruling that UCB Inc.'s Cimzia brand antibody used to treat Crohn's disease and arthritis does not infringe a patent owned by Yeda Research, saying the district court correctly applied the law in its noninfringement finding....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.